Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
| Vanda Pharmaceuticals Inc. |
| Apotex Corp. and Apotex Inc. |
| 1:2019cv02375 |
| December 30, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding Status Report. (Jacobs, Karen) |
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Francella, Thomas) |
SO ORDERED, re (14 in 1:19-cv-02375-CFC, 11 in 1:20-cv-00093-CFC, 12 in 1:20-cv-00083-CFC, 15 in 1:19-cv-02202-CFC) STIPULATION TO EXTEND TIME to file a joint submission regarding the parties' proposal for coordination/consolidation to February 26, 2020 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 2/18/2020. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC, 1:20-cv-00083-CFC, 1:20-cv-00093-CFC(fms)
|
| Filing 14 STIPULATION TO EXTEND TIME to file a joint submission regarding the parties' proposal for coordination/consolidation to February 26, 2020 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Pro Hac Vice Attorney Jennifer Rea Deneault, Nicholas Groombridge, Daniel J. Klein, and Josephine Young for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC(mal) |
| Filing 13 ANSWER to #1 Complaint, by Apotex Corp., Apotex Inc..(Francella, Thomas) |
|
Filing 12
ORDER: On or before February 14, 2020, counsel for plaintiff shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: Notice of Compliance deadline set for 2/14/2020. Signed by Judge Colm F. Connolly on 1/14/2020. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC(nmf)
|
| Pro Hac Vice Attorneys William B. Coblentz, Barry P. Golob, Aaron S. Lukas, Keri L. Schaubert for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney W. Blake Coblentz, Barry P. Golob, Aaron S. Lukas, and Keri L. Schaubert filed by Apotex Inc., Apotex Corp. Signed by Judge Colm F. Connolly on 1/9/2020. (fms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney W. Blake Coblentz, Barry P. Golob, Aaron S. Lukas, and Keri L. Schaubert - filed by Apotex Corp., Apotex Inc.. (Francella, Thomas) |
| Filing 10 NOTICE of Appearance by Gregory F. Fischer on behalf of Apotex Corp., Apotex Inc. (Fischer, Gregory) |
| Filing 9 NOTICE of Appearance by Thomas Joseph Francella, Jr on behalf of Apotex Corp., Apotex Inc. (Francella, Thomas) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/8/2020. (nmf)
|
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Filing 7 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Apotex Corp. served on 1/3/2020, answer due 1/24/2020. (Fahnestock, Derek) |
| Filing 6 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Apotex Inc. served on 1/3/2020, answer due 1/24/2020. (Fahnestock, Derek) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/22/2019. Date of Expiration of Patent: 7/27/2035.Thirty Month Stay Deadline: 7/31/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2812497.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
| Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 12/30/2019; Apotex Inc. on 12/30/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
